SET:BDMS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Bangkok Dusit Medical Services

Executive Summary

Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally.


Snowflake Analysis

Adequate balance sheet second-rate dividend payer.


Similar Companies

Share Price & News

How has Bangkok Dusit Medical Services's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BDMS has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

1.8%

BDMS

1.4%

TH Healthcare

1.2%

TH Market


1 Year Return

-11.8%

BDMS

-14.8%

TH Healthcare

-22.3%

TH Market

Return vs Industry: BDMS exceeded the TH Healthcare industry which returned -15.1% over the past year.

Return vs Market: BDMS exceeded the TH Market which returned -22.5% over the past year.


Shareholder returns

BDMSIndustryMarket
7 Day1.8%1.4%1.2%
30 Day1.8%1.1%-0.1%
90 Day16.4%13.8%19.2%
1 Year-9.7%-11.8%-12.3%-14.8%-19.1%-22.3%
3 Year19.1%12.9%2.7%-3.7%-9.2%-17.9%
5 Year22.2%12.9%13.3%3.9%2.4%-13.4%

Price Volatility Vs. Market

How volatile is Bangkok Dusit Medical Services's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Bangkok Dusit Medical Services undervalued compared to its fair value and its price relative to the market?

37.18x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: BDMS (฿22.7) is trading above our estimate of fair value (฿15.8)

Significantly Below Fair Value: BDMS is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: BDMS is poor value based on its PE Ratio (37.2x) compared to the Healthcare industry average (24.8x).

PE vs Market: BDMS is poor value based on its PE Ratio (37.2x) compared to the TH market (15x).


Price to Earnings Growth Ratio

PEG Ratio: BDMS is poor value based on its PEG Ratio (2.4x)


Price to Book Ratio

PB vs Industry: BDMS is overvalued based on its PB Ratio (4.5x) compared to the TH Healthcare industry average (2.6x).


Next Steps

Future Growth

How is Bangkok Dusit Medical Services forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?

15.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BDMS's forecast earnings growth (15.6% per year) is above the savings rate (2.3%).

Earnings vs Market: BDMS's earnings (15.6% per year) are forecast to grow slower than the TH market (19.9% per year).

High Growth Earnings: BDMS's earnings are forecast to grow, but not significantly.

Revenue vs Market: BDMS's revenue (8.9% per year) is forecast to grow slower than the TH market (9.2% per year).

High Growth Revenue: BDMS's revenue (8.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BDMS's Return on Equity is forecast to be low in 3 years time (12.5%).


Next Steps

Past Performance

How has Bangkok Dusit Medical Services performed over the past 5 years?

12.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BDMS has high quality earnings.

Growing Profit Margin: BDMS's current net profit margins (11.8%) are lower than last year (18.8%).


Past Earnings Growth Analysis

Earnings Trend: BDMS's earnings have grown by 12.9% per year over the past 5 years.

Accelerating Growth: BDMS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BDMS had negative earnings growth (-34.4%) over the past year, making it difficult to compare to the Healthcare industry average (-0.5%).


Return on Equity

High ROE: BDMS's Return on Equity (12.1%) is considered low.


Next Steps

Financial Health

How is Bangkok Dusit Medical Services's financial position?


Financial Position Analysis

Short Term Liabilities: BDMS's short term assets (฿22.7B) do not cover its short term liabilities (฿28.1B).

Long Term Liabilities: BDMS's short term assets (฿22.7B) do not cover its long term liabilities (฿30.8B).


Debt to Equity History and Analysis

Debt Level: BDMS's debt to equity ratio (36.1%) is considered satisfactory.

Reducing Debt: BDMS's debt to equity ratio has reduced from 56.4% to 36.1% over the past 5 years.

Debt Coverage: BDMS's debt is well covered by operating cash flow (48.8%).

Interest Coverage: BDMS's interest payments on its debt are well covered by EBIT (14.7x coverage).


Balance Sheet


Next Steps

Dividend

What is Bangkok Dusit Medical Services's current dividend yield, its reliability and sustainability?

2.64%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: BDMS's dividend (2.64%) is higher than the bottom 25% of dividend payers in the TH market (2.56%).

High Dividend: BDMS's dividend (2.64%) is low compared to the top 25% of dividend payers in the TH market (7.27%).


Stability and Growth of Payments

Stable Dividend: BDMS's dividend payments have been volatile in the past 10 years.

Growing Dividend: BDMS's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (90.1%), BDMS's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: BDMS's dividends in 3 years are forecast to be covered by earnings (53.1% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Bangkok Dusit Medical Services has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Chuladej Yossundharakul
Vice Chairmanno data฿6.96m0.76% ฿2.7b
Narumol Noi-Am
CFO, Acting President & Substituting Director1.5yrs฿250.00k0.031% ฿113.5m
Sripop Sarasas
Chief Administrative Officer & Director12.25yrs฿6.48mno data
Pradit Theekakul
Executive VP of Administration & Executive VP of Corporate Portfolio and Director12.25yrs฿7.06m0.076% ฿272.4m
Chatree Duangnet
Executive Advisor to CEO & Authorized Director14.25yrs฿5.93m0.028% ฿102.2m
Chairat Panthuraamphorn
Chief Operating Officer1.5yrsno datano data
Wannapa Pawavech
Corporate Accounting Directorno datano datano data
Trin Charumilind
Chief Medical Officerno datano data0.00017% ฿613.3k
Nisa Laohasomboon
Assistant Chief Finance Officerno datano datano data
Kessara Wongsekate
VP & Company Secretaryno datano datano data

1.5yrs

Average Tenure

66yo

Average Age

Experienced Management: BDMS's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Chuladej Yossundharakul
Vice Chairmanno data฿6.96m0.76% ฿2.7b
Narumol Noi-Am
CFO, Acting President & Substituting Director1.5yrs฿250.00k0.031% ฿113.5m
Sripop Sarasas
Chief Administrative Officer & Director12.25yrs฿6.48mno data
Pradit Theekakul
Executive VP of Administration & Executive VP of Corporate Portfolio and Director12.25yrs฿7.06m0.076% ฿272.4m
Chatree Duangnet
Executive Advisor to CEO & Authorized Director14.25yrs฿5.93m0.028% ฿102.2m
Santasiri Sornmani
Independent Director26.5yrs฿7.02m0.098% ฿355.3m
Arun Pausawasdi
Independent Chairmanno data฿8.98m0.024% ฿86.7m
Thongchai Jira-alongkorn
Director8.25yrs฿6.71m0.072% ฿258.2m
Weerawong Chittmittrapap
Independent Director4.75yrs฿6.50mno data
Chavalit Sethameteekul
Independent Director9.25yrs฿6.91mno data

10.8yrs

Average Tenure

67.5yo

Average Age

Experienced Board: BDMS's board of directors are seasoned and experienced ( 10.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Bangkok Dusit Medical Services Public Company Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bangkok Dusit Medical Services Public Company Limited
  • Ticker: BDMS
  • Exchange: SET
  • Founded: 1969
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ฿360.748b
  • Shares outstanding: 15.89b
  • Website: https://www.bdms.co.th/

Number of Employees


Location

  • Bangkok Dusit Medical Services Public Company Limited
  • 2, Soi Soonvijai 7
  • New Petchburi Road
  • Bangkok
  • 10310
  • Thailand

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDMSSET (The Stock Exchange of Thailand)YesOrdinary SharesTHTHBJan 1992
BDMS-FTHAMSE (Bangkok-Alien Market Stock Exchange)THB0.1 (ALIEN MARKET)THTHBJan 1992
BDUL.FOTCPK (Pink Sheets LLC)THB0.1 (ALIEN MARKET)USUSDJan 1992
6DM1BST (Boerse-Stuttgart)THB0.1 (ALIEN MARKET)DEEURJan 1992
BDMS-RSET (The Stock Exchange of Thailand)THB1(NVDR)THTHBAug 2001
BDUU.FOTCPK (Pink Sheets LLC)THB1(NVDR)USUSDAug 2001
BDUU.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDDec 2012

Biography

Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. The company owns and manages hospital groups, including Bangkok Hospital, Samitivej Hospital, BNH Hospital, Phyathai Hospital, Paolo Memorial Hospital, and Royal Hospital. It operates regenerative and preventive wellness clinics. In addition, it operates hotels; distributes cosmetic goods; provides accounting, health insurance, laboratory services, investment, information technology, training, insurance brokerage, air transportation, and property management services, as well as asset management services; and manufactures, distributes, and retails medicine and pharmaceutical products. The company has 47 hospitals in Thailand and Cambodia. Bangkok Dusit Medical Services Public Company Limited was founded in 1969 and is based in Bangkok, Thailand. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/07/01 14:55
End of Day Share Price2020/07/01 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.